CLYM·28658R106·US·equity·Healthcare - Biotechnology-Activist
CLYM (Climb Bio, Inc.) is held by 43 institutional investors as of Q4 2025. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($77.7M), VANGUARD GROUP INC ($5.4M), Point72 Asset Management, L.P. ($2.9M). Net institutional sentiment: Mixed.
See how CLYM's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer